1. Asenapine for bipolar disorder;Scheidemantel;Neuropsychiatr. Dis. Treat.,2015
2. Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder;Gonzalez;Patient Prefer. Adherence,2011
3. Saphris® (asenapine) sublingual tablets. Full prescribing information, Schering Corporation, a subsidiary of Merck & Co. Inc., Whitehouse Station, NJ. 〈https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022117s017s018s019lbl.pdf〉. (Assessed September 2017).
4. New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania;Warren;Neuropsychiatr. Dis. Treat.,2013
5. Role of sublingual asenapine in treatment of schizophrenia;Citrome;Neuropsychiatr. Dis. Treat.,2011